This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:diseases:eyes [01.26.2019] – [Recent research into AMD] sallieq | home:diseases:eyes [01.26.2019] – [Recent research into AMD] sallieq | ||
---|---|---|---|
Line 87: | Line 87: | ||
We would caution intake of supplementary antioxidants for those with ocular disease. | We would caution intake of supplementary antioxidants for those with ocular disease. | ||
+ | |||
+ | ==== Diabetic macular edema ==== | ||
+ | |||
+ | An increase in the serum levels of homocysteine was present within patients with type 2 diabetes compared to healthy individuals. The mean total plasma homocysteine levels were associated with a greater central subfield macular thickness (CSMT), average macular thickness (AMT), and average macular volume (AMV) in patients with type 2 diabetes without DME, after adjusting for age, sex, duration of diabetes, and HbA1c. | ||
+ | |||
+ | CONCLUSIONS: | ||
+ | Higher homocysteine levels were associated with an increased CSMT, AMT, and AMV in diabetic patients without DME. This link may indicate that patients with type 2 diabetes with increased levels of plasma tHcy are more prone to develop a clinical manifestation of DME. | ||
+ | |||
==== Cataracts ==== | ==== Cataracts ==== |